The epidemiology of C. accolens needs to be better studied, but some reports have suggested that it is more prevalent in healthy individuals than CRS patients. C. accolens may be protective against some pathogens that cause CRS, such as Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). C. accolens can produce a lipase enzyme that cleaves host lipids, releasing fatty acids that impede these pathogens’ in vitro development and
C. accolens may also modulate the host immune via stimulating the synthesis of cytokines that reduce inflammation and reduce the expression of pro-inflammatory genes.
However, C. accolens can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
In France, C. accolens was isolated from 51 cases of bone and joint infection (BJI) between 2005 and 2018. The BJI was chronic primarily (88.2%), orthopedic device-related (74.5%), and polymicrobial (78.4%). After a follow-up of 60.7 weeks, 20 (39.2%) treatment failures were observed, including 4 C. accolens documented relapses, primarily associated with non-optimal surgical management.
Therefore, C. accolens is a complex bacterium that can have beneficial and harmful effects on human health, depending on the context and the host factors.
Classification and Structure
Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Corynebacteriales
Family: Corynebacteriaceae
Genus: Corynebacterium
Species:-Corynebacterium accolens
Corynebacterium accolens is a gram-positive bacterium, which means it retains the crystal violet stain during the Gram staining process, appearing purple under a microscope.
The bacterium has a rod-shaped or club-shaped morphology.
It possesses a thick cell wall, primarily composed of peptidoglycan, which helps maintain the bacterium’s structure.
Corynebacterium species, including C. accolens, have mycolic acids in their cell wall, contributing to their characteristic waxy appearance.
They are non-spore-forming bacteria, meaning they do not produce endospores for survival under adverse conditions.
Antigenic Types
There is not much information available on the antigenic types of C. accolens. However, some studies have reported the presence of different strains of C. accolens based on molecular typing methods, such as rpoB gene sequencing or pulsed-field gel electrophoresis (PFGE). These methods can reveal the genetic diversity and relatedness of C. accolens isolates from different sources or locations.
One study found that C. accolens isolates from healthy individuals and CRS patients had different PFGE patterns, suggesting they belonged to different strains. Another study identified 10 C. accolens isolates from nasal swabs of healthy individuals and confirmed their identity with rpoB gene sequencing. The rpoB gene encodes the RNA polymerase beta subunit, essential for bacterial transcription and highly conserved among Corynebacterium species.
Therefore, it seems that C. accolens has some genetic variation among its isolates, but whether this translates into antigenic differences is still being determined. Further studies are needed to explore the antigenic properties and immune responses of C. accolens about its role in health and disease.
Pathogenesis
The pathogenesis of Corynebacterium accolens has yet to be fully understood, but some possible mechanisms have been proposed. One of them is the ability of this bacterium to form biofilms, which are complex colonies of microbes encircled by and adhered to a surface of a matrix of extracellular polymeric substances. Biofilms can protect bacteria from host defenses and antibiotics and facilitate their persistence and dissemination. Another possible mechanism is the ability of Corynebacterium accolens to invade and survive within host cells, such as osteoblasts (bone-forming cells). It can allow the bacterium to evade the immune system and cause chronic infections of the bone and joints. The invasion of osteoblasts by Corynebacterium accolens may involve the interaction of bacterial surface proteins with the β1 cellular integrin, a receptor that mediates cell adhesion and signaling.
Corynebacterium accolens can cause various types of infections, like endocarditis (heart valve infection), granulomatous mastitis (inflammation of the breast tissue), pelvic osteomyelitis (infection of the pelvic bone), and ocular infections (infection of the eye). Diagnosing and treating these infections might be difficult. Corynebacterium accolens is a fastidious bacterium that requires special culture media and conditions. Moreover, it may resist some antibiotics, such as penicillins, cephalosporins, and clindamycin. Therefore, more research is needed to understand the epidemiology, pathogenicity, and clinical relevance of Corynebacterium accolens and other Corynebacterium species.
Host Defenses
The host defenses of C. accolens need to be better understood. Still, some studies have suggested that its impact on human health that is both favorable and harmful depending on the context and the host factors. On the one hand, C. accolens may be protective against some pathogens that cause CRS, such as Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). C. accolens can produce a lipase enzyme that cleaves host lipids, releasing fatty acids that impede these pathogens’ in vitro development, and C. accolens may also modulate the host immune response by inducing both the reduction of pro-inflammatory gene expression and the generation of anti-inflammatory cytokines.
It can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
Clinical manifestations
A minimum of 12 weeks of sinus/facial pain, nasal congestion, rhinorrhea, post-nasal discharge, and a diminished sense of smell are among the clinical signs of chronic rhinorrhea syndrome (CRS), an inflammatory condition affecting the mucosa of the nasal cavity and paranasal sinuses. Nasal polyps-associated CRS (CRSwNP) and nasal polyp-free CRS (CRSsNP) are the two subgroups of composite rhino syndrome.
However, C. accolens can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
Therefore, the symptoms of C. accolens infection may differ according to the infection’s location and severity level. Some common symptoms may include:
Fever
Pain
Swelling
Redness
Discharge
Malaise
Fatigue
Diagnosis
Diagnosing a Corynebacterium accolens infection involves a series of steps, including:
Clinical evaluation: A healthcare professional will assess your symptoms and medical history to understand the context and potential risk factors for infection.
Physical examination: The doctor may examine the affected area for visible signs of infection.
Sample collection: The healthcare provider may sometimes collect samples from the affected area, such as skin swabs or other appropriate specimens.
Laboratory testing: The collected samples may be transferred to a lab for bacterial identification and culture. It helps confirm the presence of Corynebacterium accolens and rule out other potential pathogens.
Sensitivity testing: If the bacteria are causing an infection, sensitivity testing may be carried out to identify the best medicines for treating the specific strain of Corynebacterium accolens.
Medical history and risk factors: The doctor may also consider your medical history and any underlying health conditions that could contribute to the infection.
Control
The prevention of C. accolens infection may depend on the context and the host factors.
Proper hygiene: Practice regular and thorough handwashing with soap and water. Clean your hands after eating, using the restroom, and
encountering potentially contaminated surfaces.
Personal care: Maintain good personal hygiene by bathing regularly and using appropriate hygiene products, such as mild soaps and shampoos.
Avoid sharing personal items: Do not share personal items like towels, razors, or personal care products, as these can transmit bacteria between individuals.
Healthy lifestyle: Maintain a balanced diet, regular exercise, and sufficient sleep to support a robust immune system. A strong immune system helps prevent opportunistic infections.
Avoid unnecessary antibiotics: Overuse or misuse of Antibiotics can potentially upset the skin microbiome’s natural equilibrium, potentially allowing opportunistic bacteria like Corynebacterium accolens to thrive. Only take antibiotics when prescribed by a qualified healthcare professional.
The epidemiology of C. accolens needs to be better studied, but some reports have suggested that it is more prevalent in healthy individuals than CRS patients. C. accolens may be protective against some pathogens that cause CRS, such as Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). C. accolens can produce a lipase enzyme that cleaves host lipids, releasing fatty acids that impede these pathogens’ in vitro development and
C. accolens may also modulate the host immune via stimulating the synthesis of cytokines that reduce inflammation and reduce the expression of pro-inflammatory genes.
However, C. accolens can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
In France, C. accolens was isolated from 51 cases of bone and joint infection (BJI) between 2005 and 2018. The BJI was chronic primarily (88.2%), orthopedic device-related (74.5%), and polymicrobial (78.4%). After a follow-up of 60.7 weeks, 20 (39.2%) treatment failures were observed, including 4 C. accolens documented relapses, primarily associated with non-optimal surgical management.
Therefore, C. accolens is a complex bacterium that can have beneficial and harmful effects on human health, depending on the context and the host factors.
Classification and Structure
Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Corynebacteriales
Family: Corynebacteriaceae
Genus: Corynebacterium
Species:-Corynebacterium accolens
Corynebacterium accolens is a gram-positive bacterium, which means it retains the crystal violet stain during the Gram staining process, appearing purple under a microscope.
The bacterium has a rod-shaped or club-shaped morphology.
It possesses a thick cell wall, primarily composed of peptidoglycan, which helps maintain the bacterium’s structure.
Corynebacterium species, including C. accolens, have mycolic acids in their cell wall, contributing to their characteristic waxy appearance.
They are non-spore-forming bacteria, meaning they do not produce endospores for survival under adverse conditions.
Antigenic Types
There is not much information available on the antigenic types of C. accolens. However, some studies have reported the presence of different strains of C. accolens based on molecular typing methods, such as rpoB gene sequencing or pulsed-field gel electrophoresis (PFGE). These methods can reveal the genetic diversity and relatedness of C. accolens isolates from different sources or locations.
One study found that C. accolens isolates from healthy individuals and CRS patients had different PFGE patterns, suggesting they belonged to different strains. Another study identified 10 C. accolens isolates from nasal swabs of healthy individuals and confirmed their identity with rpoB gene sequencing. The rpoB gene encodes the RNA polymerase beta subunit, essential for bacterial transcription and highly conserved among Corynebacterium species.
Therefore, it seems that C. accolens has some genetic variation among its isolates, but whether this translates into antigenic differences is still being determined. Further studies are needed to explore the antigenic properties and immune responses of C. accolens about its role in health and disease.
Pathogenesis
The pathogenesis of Corynebacterium accolens has yet to be fully understood, but some possible mechanisms have been proposed. One of them is the ability of this bacterium to form biofilms, which are complex colonies of microbes encircled by and adhered to a surface of a matrix of extracellular polymeric substances. Biofilms can protect bacteria from host defenses and antibiotics and facilitate their persistence and dissemination. Another possible mechanism is the ability of Corynebacterium accolens to invade and survive within host cells, such as osteoblasts (bone-forming cells). It can allow the bacterium to evade the immune system and cause chronic infections of the bone and joints. The invasion of osteoblasts by Corynebacterium accolens may involve the interaction of bacterial surface proteins with the β1 cellular integrin, a receptor that mediates cell adhesion and signaling.
Corynebacterium accolens can cause various types of infections, like endocarditis (heart valve infection), granulomatous mastitis (inflammation of the breast tissue), pelvic osteomyelitis (infection of the pelvic bone), and ocular infections (infection of the eye). Diagnosing and treating these infections might be difficult. Corynebacterium accolens is a fastidious bacterium that requires special culture media and conditions. Moreover, it may resist some antibiotics, such as penicillins, cephalosporins, and clindamycin. Therefore, more research is needed to understand the epidemiology, pathogenicity, and clinical relevance of Corynebacterium accolens and other Corynebacterium species.
Host Defenses
The host defenses of C. accolens need to be better understood. Still, some studies have suggested that its impact on human health that is both favorable and harmful depending on the context and the host factors. On the one hand, C. accolens may be protective against some pathogens that cause CRS, such as Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). C. accolens can produce a lipase enzyme that cleaves host lipids, releasing fatty acids that impede these pathogens’ in vitro development, and C. accolens may also modulate the host immune response by inducing both the reduction of pro-inflammatory gene expression and the generation of anti-inflammatory cytokines.
It can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
Clinical manifestations
A minimum of 12 weeks of sinus/facial pain, nasal congestion, rhinorrhea, post-nasal discharge, and a diminished sense of smell are among the clinical signs of chronic rhinorrhea syndrome (CRS), an inflammatory condition affecting the mucosa of the nasal cavity and paranasal sinuses. Nasal polyps-associated CRS (CRSwNP) and nasal polyp-free CRS (CRSsNP) are the two subgroups of composite rhino syndrome.
However, C. accolens can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
Therefore, the symptoms of C. accolens infection may differ according to the infection’s location and severity level. Some common symptoms may include:
Fever
Pain
Swelling
Redness
Discharge
Malaise
Fatigue
Diagnosis
Diagnosing a Corynebacterium accolens infection involves a series of steps, including:
Clinical evaluation: A healthcare professional will assess your symptoms and medical history to understand the context and potential risk factors for infection.
Physical examination: The doctor may examine the affected area for visible signs of infection.
Sample collection: The healthcare provider may sometimes collect samples from the affected area, such as skin swabs or other appropriate specimens.
Laboratory testing: The collected samples may be transferred to a lab for bacterial identification and culture. It helps confirm the presence of Corynebacterium accolens and rule out other potential pathogens.
Sensitivity testing: If the bacteria are causing an infection, sensitivity testing may be carried out to identify the best medicines for treating the specific strain of Corynebacterium accolens.
Medical history and risk factors: The doctor may also consider your medical history and any underlying health conditions that could contribute to the infection.
Control
The prevention of C. accolens infection may depend on the context and the host factors.
Proper hygiene: Practice regular and thorough handwashing with soap and water. Clean your hands after eating, using the restroom, and
encountering potentially contaminated surfaces.
Personal care: Maintain good personal hygiene by bathing regularly and using appropriate hygiene products, such as mild soaps and shampoos.
Avoid sharing personal items: Do not share personal items like towels, razors, or personal care products, as these can transmit bacteria between individuals.
Healthy lifestyle: Maintain a balanced diet, regular exercise, and sufficient sleep to support a robust immune system. A strong immune system helps prevent opportunistic infections.
Avoid unnecessary antibiotics: Overuse or misuse of Antibiotics can potentially upset the skin microbiome’s natural equilibrium, potentially allowing opportunistic bacteria like Corynebacterium accolens to thrive. Only take antibiotics when prescribed by a qualified healthcare professional.
The epidemiology of C. accolens needs to be better studied, but some reports have suggested that it is more prevalent in healthy individuals than CRS patients. C. accolens may be protective against some pathogens that cause CRS, such as Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). C. accolens can produce a lipase enzyme that cleaves host lipids, releasing fatty acids that impede these pathogens’ in vitro development and
C. accolens may also modulate the host immune via stimulating the synthesis of cytokines that reduce inflammation and reduce the expression of pro-inflammatory genes.
However, C. accolens can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
In France, C. accolens was isolated from 51 cases of bone and joint infection (BJI) between 2005 and 2018. The BJI was chronic primarily (88.2%), orthopedic device-related (74.5%), and polymicrobial (78.4%). After a follow-up of 60.7 weeks, 20 (39.2%) treatment failures were observed, including 4 C. accolens documented relapses, primarily associated with non-optimal surgical management.
Therefore, C. accolens is a complex bacterium that can have beneficial and harmful effects on human health, depending on the context and the host factors.
Classification and Structure
Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Corynebacteriales
Family: Corynebacteriaceae
Genus: Corynebacterium
Species:-Corynebacterium accolens
Corynebacterium accolens is a gram-positive bacterium, which means it retains the crystal violet stain during the Gram staining process, appearing purple under a microscope.
The bacterium has a rod-shaped or club-shaped morphology.
It possesses a thick cell wall, primarily composed of peptidoglycan, which helps maintain the bacterium’s structure.
Corynebacterium species, including C. accolens, have mycolic acids in their cell wall, contributing to their characteristic waxy appearance.
They are non-spore-forming bacteria, meaning they do not produce endospores for survival under adverse conditions.
Antigenic Types
There is not much information available on the antigenic types of C. accolens. However, some studies have reported the presence of different strains of C. accolens based on molecular typing methods, such as rpoB gene sequencing or pulsed-field gel electrophoresis (PFGE). These methods can reveal the genetic diversity and relatedness of C. accolens isolates from different sources or locations.
One study found that C. accolens isolates from healthy individuals and CRS patients had different PFGE patterns, suggesting they belonged to different strains. Another study identified 10 C. accolens isolates from nasal swabs of healthy individuals and confirmed their identity with rpoB gene sequencing. The rpoB gene encodes the RNA polymerase beta subunit, essential for bacterial transcription and highly conserved among Corynebacterium species.
Therefore, it seems that C. accolens has some genetic variation among its isolates, but whether this translates into antigenic differences is still being determined. Further studies are needed to explore the antigenic properties and immune responses of C. accolens about its role in health and disease.
Pathogenesis
The pathogenesis of Corynebacterium accolens has yet to be fully understood, but some possible mechanisms have been proposed. One of them is the ability of this bacterium to form biofilms, which are complex colonies of microbes encircled by and adhered to a surface of a matrix of extracellular polymeric substances. Biofilms can protect bacteria from host defenses and antibiotics and facilitate their persistence and dissemination. Another possible mechanism is the ability of Corynebacterium accolens to invade and survive within host cells, such as osteoblasts (bone-forming cells). It can allow the bacterium to evade the immune system and cause chronic infections of the bone and joints. The invasion of osteoblasts by Corynebacterium accolens may involve the interaction of bacterial surface proteins with the β1 cellular integrin, a receptor that mediates cell adhesion and signaling.
Corynebacterium accolens can cause various types of infections, like endocarditis (heart valve infection), granulomatous mastitis (inflammation of the breast tissue), pelvic osteomyelitis (infection of the pelvic bone), and ocular infections (infection of the eye). Diagnosing and treating these infections might be difficult. Corynebacterium accolens is a fastidious bacterium that requires special culture media and conditions. Moreover, it may resist some antibiotics, such as penicillins, cephalosporins, and clindamycin. Therefore, more research is needed to understand the epidemiology, pathogenicity, and clinical relevance of Corynebacterium accolens and other Corynebacterium species.
Host Defenses
The host defenses of C. accolens need to be better understood. Still, some studies have suggested that its impact on human health that is both favorable and harmful depending on the context and the host factors. On the one hand, C. accolens may be protective against some pathogens that cause CRS, such as Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). C. accolens can produce a lipase enzyme that cleaves host lipids, releasing fatty acids that impede these pathogens’ in vitro development, and C. accolens may also modulate the host immune response by inducing both the reduction of pro-inflammatory gene expression and the generation of anti-inflammatory cytokines.
It can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
Clinical manifestations
A minimum of 12 weeks of sinus/facial pain, nasal congestion, rhinorrhea, post-nasal discharge, and a diminished sense of smell are among the clinical signs of chronic rhinorrhea syndrome (CRS), an inflammatory condition affecting the mucosa of the nasal cavity and paranasal sinuses. Nasal polyps-associated CRS (CRSwNP) and nasal polyp-free CRS (CRSsNP) are the two subgroups of composite rhino syndrome.
However, C. accolens can also cause opportunistic infections in immunocompromised patients or patients with foreign body implants, such as prosthetic joints or cardiac devices. C. accolens can form biofilms on these implants and invade osteoblasts, which may contribute to its persistence and resistance to antibiotics. C. accolens infections can manifest as osteomyelitis, septic arthritis, endocarditis, bacteremia, or wound infections.
Therefore, the symptoms of C. accolens infection may differ according to the infection’s location and severity level. Some common symptoms may include:
Fever
Pain
Swelling
Redness
Discharge
Malaise
Fatigue
Diagnosis
Diagnosing a Corynebacterium accolens infection involves a series of steps, including:
Clinical evaluation: A healthcare professional will assess your symptoms and medical history to understand the context and potential risk factors for infection.
Physical examination: The doctor may examine the affected area for visible signs of infection.
Sample collection: The healthcare provider may sometimes collect samples from the affected area, such as skin swabs or other appropriate specimens.
Laboratory testing: The collected samples may be transferred to a lab for bacterial identification and culture. It helps confirm the presence of Corynebacterium accolens and rule out other potential pathogens.
Sensitivity testing: If the bacteria are causing an infection, sensitivity testing may be carried out to identify the best medicines for treating the specific strain of Corynebacterium accolens.
Medical history and risk factors: The doctor may also consider your medical history and any underlying health conditions that could contribute to the infection.
Control
The prevention of C. accolens infection may depend on the context and the host factors.
Proper hygiene: Practice regular and thorough handwashing with soap and water. Clean your hands after eating, using the restroom, and
encountering potentially contaminated surfaces.
Personal care: Maintain good personal hygiene by bathing regularly and using appropriate hygiene products, such as mild soaps and shampoos.
Avoid sharing personal items: Do not share personal items like towels, razors, or personal care products, as these can transmit bacteria between individuals.
Healthy lifestyle: Maintain a balanced diet, regular exercise, and sufficient sleep to support a robust immune system. A strong immune system helps prevent opportunistic infections.
Avoid unnecessary antibiotics: Overuse or misuse of Antibiotics can potentially upset the skin microbiome’s natural equilibrium, potentially allowing opportunistic bacteria like Corynebacterium accolens to thrive. Only take antibiotics when prescribed by a qualified healthcare professional.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
